Author: admin

After two remote years, the Decision Science summer courses return to being fully in-person this summer. In both 2020 and 2021 the courses were taught via synchronous ZOOM sessions

Conventional benefit-cost analysis is well-established and widely used globally to assess policy options that profoundly affect public health. The normative assumptions that underlie the

CHDS faculty Stephen Resch and Research Staff Joseph Corlis produced “A Roadmap for Implementing Change in Costing Capacity and Practices” as part of a project supported by the

CHDS faculty Ankur Pandya received the 2022 Roger L. Nichols Award for Excellence in Teaching at the Harvard Chan School’s Commencement Ceremony. The award is selected through a review of

CHDS faculty Ankur Pandya outlined how economic evaluation methods could be used to improve the process of making difficult policy choices around COVID-19 in a recently co-authored 

Steven Pearson spoke about the role of the Institute for Clinical and Economic Review (ICER) in encouraging the consideration of cost-effectiveness in US drug policy in a recent CHDS seminar.

A recent study by CHDS Research Scientist Shafika Abrahams-Gessel and faculty Thomas A. Gaziano showed that federal food service guidelines improve health outcomes and are cost-saving. Despite

Nathaniel Hendrix, CHDS faculty Stéphane Verguet, and colleagues performed a systematic review of cost-effectiveness analyses that assessed activities designed to strengthen health

Alicia Yamin spoke about her work on fostering meaningful citizen participation in health priority setting during a recent CHDS seminar. Yamin is a lecturer on Law and Senior Fellow on Global Health and

CHDS Deputy Director Lisa Robinson was named a Fellow by the Society for Benefit-Cost Analysis, the Society’s highest award for contributions to theory and practice, at its March 2022 Annual Conference